Cash & equivalents increased 31.6%
Cash & equivalents changed +31.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +31.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross margin changed -6131 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross profit changed -347.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -8341 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Research & development changed +12.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed -11.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Net income changed -8.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -11.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Revenue changed -0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.